In an effort to combat OxyContin addiction and abuse, the US Food and Drug Administration (FDA) has given approval to Purdue Pharma for a new OxyContin formula. This new version of OxyContin is the first in what the FDA hopes is a long line of enhanced abuse prevention features in narcotic drugs.
Read more about OxyContin Addiction Addressed by Tablet Redesign
